Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Godson

Showing results (111-120 of 134) with videos related to

Pageof 14
Sort By:
Cardiovascular Diabetology|November 20, 2024
Lipoxin A<sub>4</sub> improves cardiac remodeling and function in diabetes-associated cardiac dysfunctionTing Fu, Muthukumar Mohan, Madhura Bose, et al.
Circulation Research|October 1, 2025
Macrophage DNases Limit Neutrophil Extracellular Trap-Mediated Defective Efferocytosis in AtherosclerosisUmesh Kumar Dhawan, Tanwi Vartak, Hanna Englert, et al.
Journal of the American Society of Nephrology : JASN|March 2, 2018
Lipoxins Regulate the Early Growth Response-1 Network and Reverse Diabetic Kidney DiseaseEoin P Brennan, Muthukumar Mohan, Aaron McClelland, et al.
Clinical Science (London, England : 1979)|October 19, 2022
Dietary restriction and medical therapy drives PPARα-regulated improvements in early diabetic kidney disease in male ratsWilliam P Martin, Meera Nair, Yeong H D Chuah, et al.
Journal of the American Society of Nephrology : JASN|March 23, 2013
Lipoxins attenuate renal fibrosis by inducing let-7c and suppressing TGFβR1Eoin P Brennan, Karen A Nolan, Emma Börgeson, et al.
Diabetes|February 18, 2026
Epigenetic Regulation of VCAM-1 by Lipoxin A4 Is Renoprotective Against Diabetic Kidney DiseaseMadhura Bose, Muthukumar Mohan, Jun Okabe, et al.
Research Square|July 1, 2024
Treatment with lipoxin A 4 improves influenza A infection outcome through macrophage reprogramming, anti-inflammatory and pro-resolutive responsesFlavia Rago, Eliza Mathias Melo, Leigh M Miller, et al.
Circulation Research|November 4, 2025
TRIB3 Links Endoplasmic Reticulum Stress to Impaired Efferocytosis in AtherosclerosisAarushi Singhal, Stefan Russo, Umesh Kumar Dhawan, et al.
Diabetes|May 11, 2017
Protective Effect of let-7 miRNA Family in Regulating Inflammation in Diabetes-Associated AtherosclerosisEoin Brennan, Bo Wang, Aaron McClelland, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|August 30, 2024
Treatment with lipoxin A<sub>4</sub> improves influenza A infection outcome, induces macrophage reprogramming, anti-inflammatory and pro-resolutive responsesFlavia Rago, Eliza Mathias Melo, Leigh M Miller, et al.
Pageof 14

Showing results (111-120 of 134) with videos related to

Sort By:
Pageof 14
Cardiovascular Diabetology|November 20, 2024
Lipoxin A<sub>4</sub> improves cardiac remodeling and function in diabetes-associated cardiac dysfunctionTing Fu, Muthukumar Mohan, Madhura Bose, et al.
Circulation Research|October 1, 2025
Macrophage DNases Limit Neutrophil Extracellular Trap-Mediated Defective Efferocytosis in AtherosclerosisUmesh Kumar Dhawan, Tanwi Vartak, Hanna Englert, et al.
Journal of the American Society of Nephrology : JASN|March 2, 2018
Lipoxins Regulate the Early Growth Response-1 Network and Reverse Diabetic Kidney DiseaseEoin P Brennan, Muthukumar Mohan, Aaron McClelland, et al.
Clinical Science (London, England : 1979)|October 19, 2022
Dietary restriction and medical therapy drives PPARα-regulated improvements in early diabetic kidney disease in male ratsWilliam P Martin, Meera Nair, Yeong H D Chuah, et al.
Journal of the American Society of Nephrology : JASN|March 23, 2013
Lipoxins attenuate renal fibrosis by inducing let-7c and suppressing TGFβR1Eoin P Brennan, Karen A Nolan, Emma Börgeson, et al.
Diabetes|February 18, 2026
Epigenetic Regulation of VCAM-1 by Lipoxin A4 Is Renoprotective Against Diabetic Kidney DiseaseMadhura Bose, Muthukumar Mohan, Jun Okabe, et al.
Research Square|July 1, 2024
Treatment with lipoxin A 4 improves influenza A infection outcome through macrophage reprogramming, anti-inflammatory and pro-resolutive responsesFlavia Rago, Eliza Mathias Melo, Leigh M Miller, et al.
Circulation Research|November 4, 2025
TRIB3 Links Endoplasmic Reticulum Stress to Impaired Efferocytosis in AtherosclerosisAarushi Singhal, Stefan Russo, Umesh Kumar Dhawan, et al.
Diabetes|May 11, 2017
Protective Effect of let-7 miRNA Family in Regulating Inflammation in Diabetes-Associated AtherosclerosisEoin Brennan, Bo Wang, Aaron McClelland, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|August 30, 2024
Treatment with lipoxin A<sub>4</sub> improves influenza A infection outcome, induces macrophage reprogramming, anti-inflammatory and pro-resolutive responsesFlavia Rago, Eliza Mathias Melo, Leigh M Miller, et al.
Pageof 14